eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
1/2011
vol. 36
 
Share:
Share:
more
 
 
abstract:

Clinical immunology
The role of TACI expression in chronic lymphocytic leukemia

Agnieszka Bojarska-Junak
,
Iwona Hus
,
Małgorzata Sieklucka
,
Agata Surdacka
,
Maria Luiza Kusz
,
Ewa Wąsik-Szczepanek
,
Anna Dmoszyńska
,
Jacek Roliński

(Centr Eur J Immunol 2011; 36 (1): 46-50)
Online publish date: 2011/03/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Transmembrane activator and CAML interactor (TACI) was identified as a receptor for BAFF and APRIL, two members of TNF ligand family. The significantly lower TACI expression on B cells from CLL patients than from normal controls raised the question of the importance of TACI in CLL pathogenesis. We investigated the relationship between TACI expression and pro- and antiapoptotic proteins expression in CLL cells. Moreover, we were interested in a possible relationship between TACI expression and prognostic factors such as: CD38 antigen or ZAP-70 protein expression, which are known poor prognosis factors in B-CLL. Our results confirm the significance of apoptosis deregulation in CLL and suggest the possible relationship between TACI expression and the clinical course of the disease.
keywords:

CLL, TACI, ZAP-70, PAR-4, DAXX, ZIPK, apoptosis

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.